Clinical Trial Update: A Study of Orforglipron in Adult Participants With Obesity or Overweight and Type 2 Diabetes [Phase 3]

View source ↗

Summary

A Phase 3 study of Orforglipron in adults with obesity or overweight and Type 2 diabetes has completed its trial.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight
• Type 2 Diabetes Mellitus

Drugs mentioned

• Orforglipron (orforglipron)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Obesity, Overweight | Phase 3 | Status: COMPLETED